So sánh tác dụng của hai phương pháp gây mê tĩnh mạch hoàn toàn bằng Propofol có và không kiểm soát nồng độ đích - 18


57. Iwakiri H., Nagata O., Matsukawa T., Ozaki M., Sessler D. I. (2003), “Effect-site concentration of propofol for recovery of consciousness is virtually independent of fentanyl effect-site concentration”, Anesthesia & Analgesia, 96 (6), pp. 1651-5.

58. Iwakiri H., Nishihara N., Nagata O., Matsukawa T., Ozaki M., Sessler

D.I. (2005), “Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening”, Anesthesia & Analgesia, 100 (1), pp. 107-10.

59. Jansson J. R., Fukada T., Ozaki M., Kimura S. (2006), “Propofol EDTA and reduced incidence of infection”. Anaesthesia and Intensive Care, 34 (3), pp. 362-8.

60. Kataria B. K., Ved S. A., Nicodemus H. F., Hoy G. R., Lea D., Dubois

M. Y., Mandema J. W., Shafer S. L. (1994), “The pharmacokinetics of propofol in children using three different data analysis approaches”, Anesthesiology, 80 (1), pp. 104-22.

61. Kaul H. L., Neerja B. (2002), “Monitoring depth of anaesthesia”, Indian J. Anaesth., 46 (4), pp. 323-32.

62. Kazama T., Ikeda K., Morita K., Kikura M., Doi M., Ikeda T., Kurita T., Nakajima Y. (1999), “Comparison of the effect-site keoof propofol for blood pressure and EEG Bispectral Index in Elderly and Younger patients”, Anesthesiology, 90 (6), pp. 1517-27.

63. Kazama T., Ikeda K., Morita K. (1997), “Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli”, Anesthesiology, 87 (2), pp. 213-27.

Có thể bạn quan tâm!

Xem toàn bộ 167 trang tài liệu này.

64. Kenny G., White M. (1992), “A portable target controlled propofol infusion system”, International Journal of Clinical Monitoring and Computing, 9 (3), pp. 179-82.


So sánh tác dụng của hai phương pháp gây mê tĩnh mạch hoàn toàn bằng Propofol có và không kiểm soát nồng độ đích - 18

65. Ke-Xuan Liu, Timo R., Wei H., Fang W., Zhengyuan X. (2007), “Propofol attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat”, Canadian Journal of Anaesthesia, 54 (5), pp. 366–74.

66. Kirkpatrick T., Cocktshoot I. D., Douglas E. J., Nimmo W. S. (1988) “Pharmacokinetics of propofol (Diprivan) in elderly patients”, Br. J. Anaesth., 60 (2), pp. 146-50.

67. Larsen R., Rathgeber J., Bagdahn A., Lange H., Rieke H. (1988), “Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients. A comparision with etomidate”, Anaesthesia, 43 (Suppl. 1), pp. 25-31.

68. Laszlo H., Nick E. M. (2001), “Effect site targeted propofol infusion in clinical practice: Comparison to Diprifusor”, The Internet Journal of Anesthesiology, 5 (3).

69. Leslie K. C. O., Hargrove J. (2008), “Target-controlled infusion versus manually-controlled infusion of propofol for general anaesthesia or sedation in adults”, Cochrane Database of Systematic Reviews, 3, John Wiley & Sons, Ltd,.

70. Li M., Xu C., Wang X. D., Zhang L. P., Guo X. Y. (2011), “A comparison of target controlled versus manually controlled infusion of propofol in elderly patients”, Zhonghua Yi Xue Za Zhi, 91 (9), pp. 600-3.

71. Lim K. H., Halestrap A. P., Angelini G. D., Suleiman M. S. (2005), “Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass”, Exp. Biol. Med., 230 (6), pp. 13-20.


72. Lim T. A., Gin T., Tam Y. H., Aun C. S., Short T. G. (1997), “Computer-controlled infusion of propofol for long neurosurgical procedures”, Journal of Neurosurgical Anesthesiology, 9 (3), pp. 242-9.

73. Liu B., Pettigrew D. M., Bates S., Laitenberger P. G., Troughton G. (2012), “Performance evaluation of a whole blood propofol analyser”, Journal of Clinical Monitoring and Computing, 26 (1), pp. 29-36.

74. Liu N., Chazot T., Genty A., Landais A., Restoux A., McGee K., Lalo P. A., Trillat B., Barvais L., Fischler M. (2006), “Titration of propofol for anesthetic induction and maintenance guided by the Bispectral Index: Closed-loop versus manual control: A Prospective, Randomized, Multicenter Study”, Anesthesiology, 104 (4), pp. 686-95.

75. Liu Shao-hua W. W., Ding Guan-nan, Ke Jing-dong, Hong Fang-xiao, Tien Ming (2009), “Relationship between depth of anesthesia and effect- site concentration of propofol during induction with the target-controlled infusion technique in elderly patients”, Chinese Medical Journal, 122 (8), pp. 935-40.

76. Mahli A., Coskun D., Karaca G.I., Akcali D.T., Karabiyik L., Karadenizli Y. (2011), “Target-controlled infusion of remifentanil with propofol or desflurane under bispectral index guidance: quality of anesthesia and recovery profile”, J. Res. Med. Sci., 16 (5), pp. 611-20.

77. Malgorzata W., Zbigniew K., Marta R., Seweryn N., Paweł S. (2012), “Comparison of target controlled infusion and total intravenous anaesthesia with propofol and remifentanil for lumbar microdiscectomy”, Anaesthesiology Intensive Therapy, 44 (3), pp. 138- 144.


78. Marsh B., White M., Morton N., Kenny G. (1991), “Pharmacokinetic model driven infusion of propofol in children”, British Journal of Anaesthesia, 67 (1), pp. 41-8.

79. Masui K., Upton R. N., Doufas A. G., Coetzee J. F., Kazama T., Mortier

E. P., Struys M. M. (2010), “The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: A comparison using bolus, continuous, and target-controlled infusion data”, Anesthesia & Analgesia, 111, pp. 368-79.

80. Mayer J., Boldt J., Triem J. G., Schellhaa A., Mengistu A. M., Suttner S. (2008), “Individual titration of propofol plasma target improves anaesthetic stability in patients undergoing major abdominal surgery: a comparison with manually controlled infusion”, European Journal of Anaesthesiology, 25 (9), pp. 741-7.

81. Mazzarella B., Melloni C., Montanini S., Novelli G. P., Peduto V. A., Santandrea E., Vincenti E., Zattoni J. (1999), “Comparison of manual infusion of propofol and target-controlled infusion: effectiveness, safety and acceptability”, Minerva Anestesiol., 65 (10), pp.701-9.

82. Minto C. F., Schnider T. W., Egan T. D., Youngs E., Lemmens H. J., Gambus P. L., Billard V., Hoke J. F., Moore K. H., Hermann D. J., Muir

K. T., Mandema J. W., Shafer S. L. (1997), “Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development”, Anesthesiology, 86 (1), pp. 10-23.

83. Monk C. K., Coates D. P., Prys-Robert C., Turtle M. J., Spelina K. (1987), “Haemodynamic effects of a prolonged infusion of propofol as a supplement to nitrous oxide anaesthesia”, Br. J. Anaesth., 59 (8), pp. 954-60.


84. Morcos W. E. (1985), “The induction of anaesthesia with propofol (Dprivan) compared in normal and renal failure patients”, Postgrad. Med. J., 61, pp. 62-3.

85. Murat I., Billard V., Vernois J., Zaouter M., Marsol P., Souron R., Farinotti R. (1996), “Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns”, Anesthesiology, 84 (3), pp. 526-32.

86. Murry C. E., Jennings R. B., Reimer K. A. (1986), “Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium”, Circulation, 74 (5), pp. 1124 – 36.

87. Naser Y., Bahman R. (2006), “A bispectral index guided comparison of target-controlled versus manuallycontrolled infusion of propofol and remifentanil for attenuation of pressor response to laryngoscopy and tracheal intubation in non cardiac surgery”, Journal of Research in Medical Sciences, 11 (5), pp. 302-8.

88. Naser Y., Bahman R., Mitra Y., Afshin A. (2010), “Target-controlled infusion anesthesia with propofol and remifentanil compared with manually controlled infusion anesthesia in mastoidectomy surgeries”. Middle East J. Anaesthesiol., 20 (6), pp. 785-793.

89. Newson C., Joshi G. P., Victory R., White P. F. (1995), “Comparison of propofol administration techniques for sedation during monitored anesthesia care”, Anesthesia & Analgesia, 81, pp. 486-91.

90. O‟Toole D. P., Milligan K., Howe J. P., McCollum J. S, Dundee J. W. (1987), “A comparison of propofol and methohexitone as induction agents for day case isoflurane anaesthesia”, Anaesthesia,42 (4), pp. 373-6.

91. Olmos M., Ballester J. A., Vidarte M. A., Elizalde J. L., Escobar A. (2000), “The combined effect of age and premedication on the propofol


requirements for induction by target-controlled infusion”, Anesthesia & Analgesia, 90 (5), pp. 1157-61.

92. Palmer J. H. M., Ball D. R. (2000), “Comparison of propofol administration techniques awake tracheal intubation with the intubating laryngeal mask in a patient with diffuse idiopathic skeletal hyperostosis”, Anaesthesia, 55, pp. 70-4.

93. Pandin P., Cantraine F, Ewalenko P. (2000), “Predictive accuracy of target-controlled propofol and sufentanil coinfusion in long-lasting surgery”, Anesthesiology, 93 (3), pp. 653-61.

94. Patrick M. R, Blair I. J., Feneck R. O., Sebel P. S. (1985), “A comparison of the haemodynamic effects of propofol (Diprivan) and thiopentone in patients with coronary artery disease”, Postgrad. Med. J., 61, pp. 23-7.

95. Peter S., Jane D. L. (1989), “Propofol a new intrevenous anesthetic”,

Anesthesiology, 71 (2), pp. 260-77.

96. Picard V., Dumont L., Pellegrini M. (2000), “Quality of recovery in children: sevoflurane versus propofol”, Acta Anaesthesiol Scand., 44, pp. 307-10.

97. Puri G. D., Mathew P. J., Sethu M. J., Hegde H. V., Fiehn A. (2011), “Bi-spectral index, ENTROPY and predicted plasma propofol concentrations with target controlled infusions in Indian patients”, Journal of Clinical Monitoring and Computing, 25 (5), pp. 309-14.

98. Reves J. G., Peter S. A. G., David A. L., Matthew D. M, Ricardo M. R. (2010), “Intravenous Anesthetics”, 7 ed. Miller’s Anesthesia, Churchill Livingstone, New York, pp. 719-768.


99. Rigouzzo A., Servin F., Constant I. (2010), “Pharmacokinetic - Pharmacodynamic modeling of propofol in children”, Anesthesiology, 113, pp. 343-52.

100. Russell D., Wilkes M. P., Hunter S. C., Glen J. B., Hutton P., Kenny G.

N. (1995), “Manual compared with target-controlled infusion of propofol”, British Journal of Anaesthesia, 75, pp. 562-6.

101. Ryll C., Herold K., Baars J., Rehberg B. (2006), “Comparison of a target controlled infusion system and manual infusion of propofol in routine anesthesia care”, European Journal of Anaesthesiology, A-116, pp. 23-29.

102. Sarla H., Kiranpreet K., Kamal N. R., Anil K. T., Kirti K. (2012), “Trapezius squeeze test as an indicator for depth of anesthesia for laryngeal mask airway insertion in children”, J. Anaesthesiol. Clin. Pharmacol., 28 (1), pp. 28-31.

103. Schuttler J., Ihmsen H. (2000), “Population pharmacokinetics of propofol”, Anesthesiology, 92 (3), pp. 727–38.

104. Schnider T. W., Minto C. F., Shafer S. L., Gambus P. L., Andresen C., Goodale D. B., Youngs E. J. (1999), “The influence of age on propofol pharmacodynamics”, Anesthesiology, 90 (6), pp. 1502-16.

105. Schraag S. (2001), “Theoretical basis of target controlled anaesthesia: history, concept and clinical perspectives”, Best Practice & Research Clinical Anaesthesiology, 15 (1), pp. 1-17.

106. Sebel P. S. B, Andrew G. T., Mohamed M. R., Ira J. P., Roger E. G., Tong J. D., Karen B. (2004), “The incidence of awareness during anesthesia: A multicenter United States study”, Anesthesia & Analgesia, 99, pp. 833-9.

107. Servin F. (1998), “TCI compared with manually controlled infusion of propofol: a multicentre study”, Anaesthesia, 53 (Suppl. 1), pp. 82-6.


108. Servin F., Farinotti R., Haberer J. P., Winckler C., Desmont J. M. (1990) “Propofol pharmacokinetics in patients with cirrhosis”, Br. J. Anaesth., 65 (2), pp. 177-83.

109. Shafer A. D. V., Shafer S. L., White P. F. (1988), “Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia”, Anesthesiology, 69 (3), pp. 348-56.

110. Shafer S. L., Vuyx J., Aziz N., Scott J. (1990), “Pharmacokinetics of fentanyl administered by computer-controlled infusion pump”, Anesthesiology, 73 (6), pp. 1091-102.

111. Shelley B., Sutcliffe N. (2010), “Total intravenous anaesthesia”,

Anaesthesia & Intensive Care Medicine,11, pp. 44-6.

112. Simons P. J, Cockshott I., Douglas E. J., Gordon E. A., Hopkins K., Rowland M. (1998), “Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emultion of 14C-propofol”, Xenobiotica, 18 (4), pp. 429-40.

113. Sivasubramaniam S. (2007), “Target controlled infusions in anaesthetic practice”, Anaesthesia tutorial of the week 75, pp. 1-10.

114. Smith C. M. A., Jhaveri R., Wilkinson M., Goodman D., Smith L. R., Canada A. T., Glass P. S. (1994), “The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision”, Anesthesiology, 81 (4), pp. 820-8.

115. Sreevastava D. K., Upadhyaya K. K., et al. (2008), “Automated target controlled infusion systems: The future of total intravenous anaesthesia”, MJAFI, 64 (3), pp. 261-262.

116. Stokes D. N., Hutton P. (1991), “Rate-dependent induction phenomena with propofol: implications for therelative potency of intravenous anesthetics”, Anesthesia and Analgesia, 72 (5), pp. 578-83.

Xem toàn bộ nội dung bài viết ᛨ

..... Xem trang tiếp theo?
⇦ Trang trước - Trang tiếp theo ⇨

Ngày đăng: 12/11/2022